(Press-News.org) The Spallation Neutron Source at the Department of Energy's Oak Ridge National Laboratory set a world record when its particle accelerator beam operating power reached 1.7 megawatts, substantially improving on the facility’s original design capability.
The accelerator’s higher power provides more neutrons for researchers who use the facility to study and improve a wide range of materials for more efficient solar panels, longer–lasting batteries and stronger, lighter materials for transportation. The achievement marks a new operational milestone for neutron scattering in the United States and opens the door to tackling more difficult questions and problems in materials science research.
“This increase in beam power represents another milestone in the Proton Power Upgrade project, an essential component in enabling new science at the SNS, including insights into advanced materials for clean energy applications,” said interim ORNL Director Jeff Smith. “I commend our staff for their efforts in accomplishing this new record.”
Since construction was completed in 2006, the SNS has been a world-leading DOE Office of Science user facility that provides powerful advanced scientific capabilities for thousands of researchers from around the world to study energy phenomena and materials down to the atomic scale.
The facility produces neutrons by accelerating protons down a 300-meter-long linear accelerator, around an accumulator ring and into a liquid mercury target. Upon impact, a “spall” of neutrons is routed to surrounding research instruments, which enables scientists to study the atomic structure and behavior of various materials. Neutrons scatter off atoms within the material and are captured by high-speed detectors, revealing fundamental information for research teams to analyze.
A megawatt is a unit of measure of the beam power of a particle accelerator. The SNS’ 1.7-megawatt power level was reached after the recent installation of additional accelerating systems, part of the ongoing Proton Power Upgrade project at the accelerator.
ORNL’s Proton Power Upgrade will continue to push the particle accelerator’s beam power up to 2.8 megawatts. This will increase the number of neutrons available for experiments at the existing First Target Station to enable new discoveries and power the planned Second Target Station, a complementary third neutron source at ORNL. STS will address emerging science challenges through experiments not currently feasible nor routine, with the ability to study smaller or less-concentrated samples or those under more extreme environmental conditions.
Besides SNS, ORNL is home to the High Flux Isotope Reactor. Completed in 1965 and operating at 85 megawatts, HFIR’s steady-state neutron beam is the strongest reactor-based neutron source in the United States.
The SNS and HFIR facilities produce neutron beams that help spur innovations that lead to improvements in daily life, such as more powerful computers, cleaner air, more effective drugs and longer-lasting batteries.
SNS and HFIR are DOE Office of Science user facilities.
UT-Battelle manages ORNL for the Department of Energy’s Office of Science, the single largest supporter of basic research in the physical sciences in the United States. The Office of Science is working to address some of the most pressing challenges of our time. For more information, please visit energy.gov/science.
END
Spallation Neutron Source accelerator achieves world-record 1.7-megawatt power level to enable more scientific discoveries
2023-07-21
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
NIH awards will fund post-treatment Lyme disease syndrome research
2023-07-21
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded five projects for research to better understand Post-treatment Lyme Disease Syndrome (PTLDS), which is a collection of symptoms, such as pain, fatigue, and difficulty thinking or “brain fog,” which linger following standard treatment for Lyme disease. The Centers for Disease Control and Prevention estimates that 476,000 people in the United States are infected with Lyme disease each year. Between 10 and 20% of ...
House Appropriations bill would slash life-saving medical research, disease prevention and treatment
2023-07-21
WASHINGTON—The Endocrine Society opposes severe funding cuts proposed in the House Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS) funding bill that would put life-saving endocrine research, disease prevention, and treatment at risk.
The House Appropriations Committee is planning to mark up the Labor-HHS funding bill before Congress leaves for its August recess.
The proposed funding levels in the Labor-HHS bill would harm America’s public health infrastructure and restrict research investments needed to develop next-generation cures. Cutting funding will reduce or eliminate services ...
Mayo Clinic researchers pave the way for individualized obesity therapy, tailoring interventions to a person’s needs
2023-07-21
ROCHESTER, Minn. — In a pilot study of 165 people, Mayo Clinic researchers looked at the effectiveness of two different approaches to weight loss: a standard lifestyle intervention and individualized therapy. The standard lifestyle intervention included a reduced diet, exercise and behavior therapy. The individualized approach was based on phenotypes and included different interventions depending on the person's predominant underlying cause of obesity. A diet based on phenotypes considers a person's ...
Deep-dive into one state's telehealth use shows key trends and policy opportunities
2023-07-21
In just three years, millions of people across Michigan’s two huge peninsulas have taken advantage of their newfound ability to connect with their doctors, nurses and therapists through a computer or phone, a new report shows.
Between 11% and 17% of all appointments to evaluate symptoms or discuss treatment now take place virtually, depending on the type of insurance, the analysis shows.
That’s up from less than 1% of such visits before the COVID-19 pandemic suddenly spurred temporary flexibility in health insurance rules for telehealth, according to the report by a team from the University of Michigan Institute for Healthcare ...
Bodybuilding supplement may help stave off Alzheimer’s
2023-07-21
The secret to protecting your memory may be a staple of a bodybuilder’s diet. RUSH researchers recently discovered that a muscle-building supplement called beta-hydroxy beta-methylbutyrate, also called HMB, may help protect memory, reduce plaques and ultimately help prevent the progression of Alzheimer’s disease.
HMB is not a prescription drug or a steroid, but an over-the-counter supplement that is available in sports and fitness stores. Bodybuilders regularly use HMB to increase exercise-induced gains in muscle size and strength while improving exercise performance. HMB is considered safe even after long-term ...
IU team contributes six research papers to Human BioMolecular Atlas Program collection in Nature
2023-07-21
Katy Börner’s team from the Luddy School of Informatics, Computing, and Engineering’s Cyberinfrastructure for Network Science Center has made significant contributions to constructing a Human Reference Atlas and has led or co-authored six research articles in a just-released HuBMAP package in Nature.
Börner, Victor H. Yngve distinguished professor of engineering and information science, and CNS director, leads one of the two mapping components within the NIH-funded Human BioMolecular Atlas Program. Her team includes ...
Research supporting increased crop growth published in Proceedings of the National Academy of Sciences
2023-07-21
NORMAN, OKLA. – An article describing research conducted by John Peters, Ph.D., chair of the Department of Chemistry and Biochemistry, Dodge Family College of Arts and Sciences at the University of Oklahoma, and fellow researchers, has been published in the journal Proceedings of the National Academy of Sciences.
The article “Structural insights into redox signal transduction mechanisms in the control of nitrogen fixation by the NifLA system” explores the way bacteria regulate the expression of genes related to nitrogen fixation – the conversion of nitrogen in the air into ammonia that can help plants grow.
“Using small angle X-ray scattering ...
Fiber optic sensing tracks seismicity from injected carbon dioxide at Australian site
2023-07-21
Researchers at a field site in Victoria, Australia are among the first to use fiber optic distributed acoustic sensing (DAS) for high-precision tracking of induced seismicity from a small carbon dioxide (CO2) injection, according to a new study published in Seismological Research Letters.
The CO2CRC Otway Project in Victoria is a research test site for the subsurface storage of carbon dioxide, as one possible way to reduce the impacts of climate-warming carbon emissions. However, there is a risk of induced earthquakes after gigatons of carbon dioxide will be injected within the same geologic ...
Biosurfactants might offer an environmentally friendly solution for tackling oil spills
2023-07-21
Can biosurfactants increase microbiological oil degradation in North Sea seawater? An international research team from the universities of Stuttgart und Tübingen, together with the China West Normal University and the University of Georgia, have been exploring this question and the results have revealed the potential for a more effective and environmentally friendly oil spill response.
Oil leaks into the oceans are estimated at approximately 1500 million liters annually worldwide. This leads to globally significant environmental pollution, as oil contains hazardous compounds ...
Revealing HIV drug-resistance mechanisms through protein structures
2023-07-21
LA JOLLA (July 21, 2023)—Salk Institute researchers, in collaboration with the National Institutes of Health, have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to Dolutegravir, one of the most effective, clinically used antiviral drugs for treating HIV.
The new study, published July 21, 2023 in Science Advances, reveals how changes to the 3D structures of integrase, an HIV protein, can lead to Dolutegravir resistance and how other compounds may be able to overcome this resistance.
“With HIV, one must think two steps ahead of the virus,” says ...